GBS Global Biopharma
Manufacturing · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
200-900 Morrison Dr, Ottawa, Ontario, K2...Phone Number
(866) 721-0297Website
www.gbsglobalbiopharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About GBS Global Biopharma
GBS Global Biopharma, Inc. is a plant-based research and biopharmaceutical drug development company focused on creating patented formulations for prescription medications. The company has achieved significant results in therapies for Parkinson's disease and COVID-related cytokine release syndrome. Utilizing their PhAROS Drug Discovery Platform, they employ AI technology to identify effective combinations of plant-derived active ingredients. Their intended clients include research partners and development partners in the pharmaceutical industry, aiming to translate innovative drug principles into real-world medicines.Explore more
GBS Global Biopharma Org Chart
MF
President & Global of Gbs Biopharma, Inc Boar...
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is GBS Global Biopharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if GBS Global Biopharma is spiking on competitors!
GBS Global Biopharma, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at GBS Global Biopharma
Earning: See what the market has to say on GBS Global Biopharma recently announced quarterly report
Product Launch: Get notified when GBS Global Biopharma launches new products
Funding: Get notified immidiatlly once GBS Global Biopharma has new funding data
Click to see if GBS Global Biopharma had a recent Job posting/layoffs
Check if GBS Global Biopharma has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at GBS Global Biopharma
Find more new buyers
Compare Similar Companies to GBS Global Biopharma
Compare insights from companies similar to GBS Global Biopharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
GBS Global Biopharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
GBS Global Biopharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about GBS Global Biopharma.
GBS Global Biopharma Tech Stack
A closer look at the technologies used by GBS Global Biopharma
See more technologies
GBS Global Biopharma News & Media
Gary Herman Joins GB Sciences' Subsidiary GbS Global Biopharma as Advisory Director
Herman will bring his experience as an investor in undervalued growth companies to this role as Advisory DirectorGB Sciences Begins Proof of Concept Studies with Michigan State University for the Treatment of Cytokine Release Syndrome
If successful, data from this preclinical study would be used as part of the support for an Independent New Drug (IND)-filing with the US Food and Drug Administration (FDA) for the use of GBS' Cannabinoid Containing Complex Mixtures (CCCM™) to treat the potentially-fatal Cytokine Release Syndrome associated with COVID-19 and other dangerous hyperinflammatory conditions.GB Sciences Files Provisional Patent Application for the Treatment of Chronic Inflammation Utilizing Its Novel Cannabinoid Containing Complex Mixtures (CCCM)
This marks the 11th U.S. provisional patent application filed by GBS covering the use of CCCM™ for unique medical disorders, creating an IP portfolio that contains formulas for up to 50 potential therapeutic indications.GB Sciences Files Provisional Patent Application for the Treatment of COVID-19-Related Acute Respiratory Distress Syndrome (ARDS), the Leading Cause of Hospitalization and Deaths, Utilizing Its Cannabinoid Containing Complex Mixtures (CCCM™)
Based on data from a two-year study, GBS's CCCM were designed for the treatment of Cytokine Storm Syndromes, while preserving anti-viral immune reactions
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding GBS Global Biopharma
Sign Up For FreeTo access detailed company insights
GBS Global Biopharma, Inc. is a plant-based research and biopharmaceutical drug development company focused on creating patented formulations for prescription medications. The company has achieved significant results in therapies for Parkinson's disease and COVID-related cytokine release syndrome. Utilizing their PhAROS Drug Discovery Platform, the... Read More
